This Week in European MedTech and HealthTech: 19th June 2026
NA
Here's what's moved in European HealthTech over the past week, with the sector's attention firmly on Amsterdam.
European HealthTech
The headline is HLTH Europe 2026, running 15–18th June at the RAI Amsterdam under the theme "Step Outside". 5,000+ attendees from 50+ countries, one in three at C-suite level. It's the dominant gathering of the week, with company announcements (product launches, partnerships, research) being refreshed daily on the show floor and the Health Transformation Summit convening 200+ payer/provider CEOs and policymakers.
Funding
On funding, the standout was Semble's £30M Series C, led by Revaia with Partech and Octopus Ventures, to expand its open, interoperable clinical platform into France and larger European groups. Around it, a cluster of smaller AI-led rounds: 01Health ($15M Series A, specialist healthcare infrastructure, UK),
Uncovr ($7M for surgical AI handling post-op documentation and workflow), OurMind (€2.1M, Dutch, clinical admin automation), TurnUp (€2M, Ghent, reducing no-shows for medical/dental practices), and Nanordica Medical (€1.6M, Estonia, antibiotic-free chronic wound care).
On the capital-formation side, Thena Capital closed a £45M debut fund, led entirely by female GPs, to back up to 25 early-stage health and MedTech startups. Tech.eu data shows capital concentrating into larger, commercial rounds, led by the UK (€2.5Bn), Switzerland (~€1.0Bn) and Finland (€881M).
Regulation
Regulation produced the most friction. A political agreement on the Digital Omnibus amending the EU AI Act confirmed that AI medical devices will stay subject to parallel compliance under both the AI Act and MDR, a blow to MedTech Europe, which had lobbied for sector-specific rules only. Industry is mobilising to simplify the overlap, which Parliament estimates could save up to €3.3Bn annually.
More positively, the EMA launched an innovation pilot for Class III and implantable devices, seen as a step toward a US-style breakthrough-device pathway. And the UK MHRA published draft Medical Devices (Amendment) Regulations 2026 introducing an "International Reliance Pathway", letting devices already cleared by trusted regulators (e.g. FDA) reach the GB market via a fast-tracked review.
A quieter but important thread: diluted EU "AI literacy" training requirements are raising manufacturer liability exposure if clinicians misinterpret AI outputs, against a backdrop where the Philips Future Health Index 2026 reports 65% of European clinicians have increased medical-AI use.
European MedTech
Here's the MedTech-specific picture this week, distinct from the HealthTech/software developments, the action sat mostly in regulation and policy, set against HLTH Europe running in Amsterdam (15–18 June).
Regulation was the dominant story.
A political agreement on the Digital Omnibus amending the EU AI Act confirmed that AI-enabled medical devices will remain under parallel compliance from both the AI Act and MDR/IVDR, rather than sector-specific medical rules alone.
MedTech Europe and industry leaders pushed back hard, calling it "an unnecessary layer of complexity"; the lobby is mobilising to simplify the overlap, which Parliament estimates could save the industry up to €3.3Bn a year. This sits on top of the Commission's December 2025 proposal to harmonise AI Act requirements with MDR/IVDR (observers expect adoption by summer 2026), and signals that high-risk compliance deadlines may slip to December 2027 (standalone systems) and August 2028 (AI embedded in regulated devices).
Two more constructive regulatory moves: the EMA launched an innovation pilot for Class III and implantable devices, widely read as a precursor to a US-style "breakthrough device" pathway; and the UK MHRA published draft Medical Devices (Amendment) Regulations 2026 introducing an International Reliance Pathway, letting devices already cleared by trusted regulators (e.g. FDA) reach the GB market via a fast-tracked review. On the UK side, the government is also championing a new NICE national HealthTech access programme to speed adoption across the NHS, a meaningful market-access signal for device makers.
On adoption and liability, the newly released Philips Future Health Index 2026 found ~65% of European clinicians have increased medical-AI use to save time, but experts flagged a growing manufacturer liability risk, because diluted EU "AI literacy" training requirements leave makers exposed if a clinician misreads an AI device's output.
Device funding and deals were quieter and smaller-ticket on the European side this week, e.g. Nanordica Medical (€1.6M, Estonia) advancing antibiotic-free chronic wound care. The bigger context is momentum: 2026 MedTech M&A is tracking at a decade-high pace (PwC), with AI "tuck-in" deals expected to drive further acceleration, though this week's billion-dollar moves were largely US/global rather than European.
Nelson Advisors > European MedTech and HealthTech Investment Banking
Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk
Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech
Nelson Advisors LLP
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Meet Nelson Advisors @ 2026 Events
Digital Health Rewired > March 2026 > Birmingham, UK
NHS ConfedExpo > June 2026 > Manchester, UK
HLTH Europe > June 2026, Amsterdam, Netherlands
HIMSS AI in Healthcare > July 2026, New York, USA
Bits & Pretzels > September 2026, Munich, Germany
World Health Summit 2026 > October 2026, Berlin, Germany
HealthInvestor Healthcare Summit > October 2026, London, UK
HLTH USA 2026 > October 2026, USA
Barclays Health Elevate > October 2026, London, UK
Web Summit 2026 > November 2026, Lisbon, Portugal
MEDICA 2026 > November 2026, Düsseldorf, Germany
Venture Capital World Summit > December 2026 Toronto, Canada